CoAprovel

Medicinal product

(Invented) name

CoAprovel

Active substance (s)

Irbesartanas/Hidrochlorotiazidas

Strength

150 mg/12,5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09DA04, Irbesartan and diuretics

Marketing authorisation holder

Sanofi Winthrop Industrie, Prancūzija

Date of authorisation

1998-10-15

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

tablet	1 vnt.
Irbesartanas	150 mg
Hidrochlorotiazidas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
320	6278	1006278	lizdinė plokštelė	N28		Receptinis	EU/1/98/086/001	Netiekiama	-	-	No	-	-
25650	28250	1028250	lizdinė plokštelė	N56		Receptinis	EU/1/98/086/002	Netiekiama	-	-	No	-	-
25651	28251	1028251	lizdinė plokštelė	N98		Receptinis	EU/1/98/086/003	Netiekiama	-	-	No	-	-
25656	28256	1028256	lizdinė plokštelė	N14		Receptinis	EU/1/98/086/007	Netiekiama	-	-	No	-	-
25657	28257	1028257	dalomoji lizdinė plokštelė	N56x1		Receptinis	EU/1/98/086/009	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
1998-10-15	Registruotas